Delivery Order HHSN272201300018I-HHSN27200019
Award Date 7/26/17
Potential Completion Date 3/31/25
Potential Value $7.1M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Atlanta, GA 30322, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
9
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a delivery order contract to Emory University Office of Sponsored Programs Division on April 19, 2017 for "Vaccine Treatment and Evaluation Units" services. The contract has a potential value of $543,459.23 and a completion date of December 31, 2021. This delivery order is part of the larger Vaccine and Treatment Evaluation Units (VTEU) indefinite...
- This delivery order against the Vaccine and Treatment Evaluation Units (VTEU) master IDIQ contract was awarded to Emory University by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases. The $343,922.96 potential value order is for services under the VTEU program's major program code for Vaccine Treatment and Evaluation Units. Performance will take place in Atlanta, Georgia through May 2020. No set-aside designation...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Emory University, a private research institution in Atlanta, Georgia. The contract, with a ceiling value of $2,671,844.24, is for overall administration, clinical operations support, and concept and protocol development, implementation, and assays related to the VACCINE TREATMENT AND EVALUATION UNITS (VTEU) program. This contract is...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded Emory University a delivery order contract for Vaccine Treatment and Evaluation Units (VTEU) services. The contract has a potential value of $4,337,100.57 and runs from July 2017 through October 2019. This delivery order is part of the larger VTEU contract vehicle, which allows the government to procure clinical trial and data collection services...
- This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Emory University, a private research institution, with a ceiling value of $1,050,622.47. The delivery order is under the Vaccine and Treatment Evaluation Units (VTEU) Indefinite Delivery Contract, which enables NIAID to fund research and development of medical countermeasures against infectious diseases, including those...
- This federal contract award is for the Vaccine Treatment and Evaluation Units (VTEU) program, which is managed by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract, valued at $1,670,222.75, was awarded to Emory University, a private research institution in Atlanta, Georgia, to provide services related to the development and evaluation of vaccines and treatments for infectious diseases. The contract is a...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, to Emory University, a private research institution in Atlanta, Georgia. The contract, valued at $6,963,671.38, is part of the Vaccine and Treatment Evaluation Units (VTEU) program, which supports the development and evaluation of vaccines and treatments for infectious diseases. The contract has no set-aside designation. Emory University,...
- This is a delivery order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Emory University in the amount of $1,209,390.27. The purpose is to transfer active work from a previous contract (HHSN272200800005C) to the Vaccine and Treatment Evaluation Units (VTEU) Indefinite Delivery Indefinite Quantity (IDIQ) contract (HHSN27220130018I). This delivery order does not have a set-aside...
- This is a federal contract award to Emory University, a private research institution in Atlanta, Georgia, by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH). The contract, with a ceiling value of $5,025,057.70, is for the development, implementation, and research of laboratory assays for a Phase I clinical trial to examine the safety, immunogenicity, and 'omics response to MVA-multi filo and AD26 Zaire vaccines in healthy...
- This is a Delivery Order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Emory University, a private research institution in Atlanta, Georgia. The contract is part of the Vaccine and Treatment Evaluation Units (VTEU) program, which supports the development and evaluation of vaccines and treatments for infectious diseases. The Delivery Order, with a ceiling value of $4,606,034.89, covers overall...
- HHSN272201300018IIndefinite Delivery Contract
- HHSN272201300018I-HHSN27200019Delivery Order
This task order was awarded to Emory University's Office of Sponsored Programs Division by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases. The $7,062,992.00 task order supports the Vaccine and Treatment Evaluation Units (VTEU) program, which focuses on vaccine and treatment development and evaluation. Specifically, this task order covers protocol development and implementation for a Phase II influenza vaccine trial. The work will be performed in Atlanta, Georgia, with a completion date of March 31, 2025. No set-aside designation was used for this award.
Generated 3/27/24, 10:18 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
VACCINE AND TREATMENT EVALUATION UNITS (VTEU) | RFP-NIAID-DMID-NIHAI2012144 | Department of Health and Human Services National Institutes of Health | Award Notice 1/2 | 4/27/12, 1:53 PM | |
VACCINE AND TREATMENT EVALUATION UNITS (VTEU) | RFP-NIAID-DMID-NIHAI2012144 | Department of Health and Human Services National Institutes of Health | Award Notice 2/2 | 6/5/12, 2:56 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00005 | Supplemental Agreement for work within scope | $0 | 3/26/24 | |
| P00004 | Supplemental Agreement for work within scope | $5.0k | 9/7/22 | |
| P00003 | Supplemental Agreement for work within scope | $0 | 1/31/22 | |
| P00002 | Supplemental Agreement for work within scope | $0 | 3/5/21 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 4/1/20 |